enVVeno Medical CorpNVNO

時価総額

$323万

PER

	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Selling, general and administrative expenses	6	5	5	11	15	12
Research and development expenses	1	2	4	6	10	14
Research and development expenses	1	2	4	6	10	14
Selling, general and administrative expenses	6	5	5	11	15	12
Loss from Operations	-7,854,785	-7,675,312	-9,135,126	-16,892,503	-25	-25
Gain on extinguishment of note payable	1	-	-	312,700	-	-
Realized gain from sales of trading securities	-	-	-	-	-	1
Realized gain from sales of trading securities	-	-	-	-	0	-
Unrealized loss from Investments	-	-	-	-	0	0
Unrealized gain from trading securities	-	-	-	-	0	-
Interest income	-	-	-	-	-	0
Interest income, net	-	-49,915	-3,739	18,709	0	-
Total Other Income	5	-49,915	360	364,681	0	2
Other income	-	-	-	33,272	-	-
Total Other (Income) Expense	5	-49,915	360	364,681	0	2
Net Loss	-13,042,709	-7,625,397	-9,135,486	-16,527,822	-25	-24
Net Loss Per Basic Common Share:	-	-	-	-	-2.2	-1.91
Net Loss	-13,042,709	-7,625,397	-9,135,486	-16,527,822	-25	-24
Net Loss Per Diluted Common Share:	-	-	-	-	-	-1.91
Net Loss Per Basic Common Share:	-	-	-	-	-2.2	-1.91